{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:26:49Z","timestamp":1778542009802,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The purpose of this study is to determine the epidemiology of tumors of the ocular adnexa and orbit in Japan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a retrospective study on the histopathological reports in the medical records of the Chiba University Hospital from April 2009 to March 2019. Three hundred and seventy two records were examined. In addition, we examined the annual changes in the major types of tumors including malignant lymphomas and IgG4-related diseases (IgG4-RDs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 270 conjunctival or eyelid tumors with 166 benign and 104 malignant. There were 102 orbital tumors with 55 benign, 47 malignant tumors, and 21 cases of IgG4-RDs. Ten cases of adenoma (2.7%), another benign tumor, was also diagnosed. The major malignant tumors were malignant lymphoma in 74 cases, sebaceous gland carcinoma (SGC) in 28 cases, basal cell carcinoma in 15 cases, and squamous cell carcinoma in 8 cases. The SGCs were the most common malignant eyelid tumor at 54%. Among the malignant lymphomas, extranodal marginal zone lymphomas of the mucosa-associated lymphoid tissue type, MALT lymphomas, was the most common at 51 cases and the second most common was the diffuse large B-cell lymphoma at 11 cases. The ratio of MALT lymphomas to that of all malignant lymphomas increased significantly with years. The serum IgG4 values were measured more often in the last 5\u2009years (70%) than in the former 5\u2009years (33%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We conclude that malignant lymphoma is a major malignant tumor in Japan and pathological biopsies should be done proactively to prevent missing IgG4-positive MALT lymphomas.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-021-02108-w","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T09:58:09Z","timestamp":1632391089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Ten-year epidemiological study of ocular and orbital tumors in Chiba University Hospital"],"prefix":"10.1186","volume":"21","author":[{"given":"Norihiro","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Oshitari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Yotsukura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Yokouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"issue":"2","key":"2108_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2108_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000491549","volume":"5","author":"S Kaliki","year":"2019","unstructured":"Kaliki S, Bothra N, Bejjanki KM, Nayak A, Ramappa G, Mohamed A, et al. Malignant eyelid tumors in India: a study of 536 Asian Indian patients. Ocul Oncol Pathol. 2019;5(3):210\u20139.","journal-title":"Ocul Oncol Pathol"},{"issue":"3","key":"2108_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1442-9071.2006.01192.x","volume":"34","author":"K Shikishima","year":"2006","unstructured":"Shikishima K, Kawai K, Kitahara K. Pathological evaluation of orbital tumours in Japan: analysis of a large case series and 1379 cases reported in the Japanese literature. Clin Exp Ophthalmol. 2006;34(3):239\u201344.","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"2108_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10384-005-0229-5","volume":"49","author":"H Takamura","year":"2005","unstructured":"Takamura H, Yamashita H. Clinicopathological analysis of malignant eyelid tumor cases at Yamagata university hospital: statistical comparison of tumor incidence in Japan and in other countries. Jpn J Ophthalmol. 2005;49(5):349\u201354.","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"2108_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s10384-013-0266-4","volume":"57","author":"Japanese study group of IgG4-related ophthalmic disease","year":"2013","unstructured":"Japanese study group of IgG4-related ophthalmic disease. A prevalence study of IgG4-related ophthalmic disease in Japan. Jpn J Ophthalmol. 2013;57(6):573\u20139.","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"2108_CR6","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.ophtha.2003.01.002","volume":"111","author":"JA Shields","year":"2004","unstructured":"Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery lecture, part 1. Ophthalmology. 2004;111(5):997\u20131008.","journal-title":"Ophthalmology."},{"issue":"3","key":"2108_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/DAD.0b013e3181961861","volume":"31","author":"M Deprez","year":"2009","unstructured":"Deprez M, Uffer S. Clinicopathological features of eyelid skin tumors. A retrospective study of 5504 cases and review of literature. Am J Dermatopathol. 2009;31(3):256\u201362.","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"2108_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/S0161-6420(99)90161-6","volume":"106","author":"BE Cook Jr","year":"1999","unstructured":"Cook BE Jr, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology. 1999;106(4):746\u201350.","journal-title":"Ophthalmology"},{"issue":"9","key":"2108_CR9","first-page":"573","volume":"109","author":"H Obata","year":"2005","unstructured":"Obata H, Aoki Y, Kubota S, Kanai N, Tsuru T. Incidence of benign and malignant lesions of eyelid and conjunctival tumors. Nippon Ganka Gakkai Zasshi. 2005;109(9):573\u20139 Japanese.","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"8","key":"2108_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1440-1827.2008.02260.x","volume":"58","author":"M Izumi","year":"2008","unstructured":"Izumi M, Mukai K, Nagai T, Matsubayashi J, Iwaya K, Chiu CS, et al. Sebaceous carcinoma of the eyelids: thirty cases from Japan. Pathol Int. 2008;58(8):483\u20138.","journal-title":"Pathol Int"},{"issue":"1","key":"2108_CR11","first-page":"175","volume":"27","author":"M Abe","year":"1983","unstructured":"Abe M, Ohnishi Y, Hara Y, Shinoda Y, Jingu K. Malignant tumor of the eyelid--clinical survey during 22-year period. Jpn J Ophthalmol. 1983;27(1):175\u201384.","journal-title":"Jpn J Ophthalmol"},{"issue":"2","key":"2108_CR12","first-page":"1","volume":"1","author":"H Toshida","year":"2012","unstructured":"Toshida H, Mamada N, Fujimaki T, Funaki T, Ebihara N, Murakami A, et al. Incidence of benign and malignant eyelid tumors in Japan. Int J Ophthalmic Pathol. 2012;1(2):1\u20133.","journal-title":"Int J Ophthalmic Pathol"},{"key":"2108_CR13","first-page":"453091","volume":"2015","author":"YY Huang","year":"2015","unstructured":"Huang YY, Liang WY, Tsai CC, Kao SC, Yu WK, Kau HC, et al. Comparison of the clinical characteristics and outcome of benign and malignant eyelid tumors: an analysis of 4521 eyelid tumors in a tertiary medical center. Biomed Res Int. 2015;2015:453091.","journal-title":"Biomed Res Int"},{"issue":"2","key":"2108_CR14","first-page":"150","volume":"19","author":"M Ho","year":"2013","unstructured":"Ho M, Liu DT, Chong KK, Ng HK, Lam DS. Eyelid tumours and pseudotumours in Hong Kong: a ten-year experience. Hong Kong Med J. 2013;19(2):150\u20135.","journal-title":"Hong Kong Med J"},{"issue":"11","key":"2108_CR15","first-page":"1835","volume":"11","author":"SS Yu","year":"2018","unstructured":"Yu SS, Zhao Y, Zhao H, Lin JY, Tang X. A retrospective study of 2228 cases with eyelid tumors. Int J Ophthalmol. 2018;11(11):1835\u201341.","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"2108_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/0974-620X.71885","volume":"3","author":"UK Wali","year":"2010","unstructured":"Wali UK, Al-Mujaini A. Sebaceous gland carcinoma of the eyelid. Oman J Ophthalmol. 2010;3(3):117\u201321.","journal-title":"Oman J Ophthalmol"},{"issue":"6","key":"2108_CR17","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/bjo.83.6.742","volume":"83","author":"M Cahill","year":"1999","unstructured":"Cahill M, Barnes C, Moriarty P, Daly P, Kennedy S. Ocular adnexal lymphoma-comparison of MALT lymphoma with other histological types. Br J Ophthalmol. 1999;83(6):742\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"2108_CR18","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","volume":"15","author":"C Thieblemont","year":"1997","unstructured":"Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, Dumontet C, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol. 1997;15(4):1624\u201330.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2108_CR19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","volume":"95","author":"C Thieblemont","year":"2000","unstructured":"Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood. 2000;95(3):802\u20136.","journal-title":"Blood."},{"issue":"1","key":"2108_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/annonc\/mdj025","volume":"17","author":"K Tanimoto","year":"2006","unstructured":"Tanimoto K, Kaneko A, Suzuki S, Sekiguchi N, Maruyama D, Kim SW, et al. Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma. Ann Oncol. 2006;17(1):135\u201340.","journal-title":"Ann Oncol"},{"issue":"2","key":"2108_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10238-017-0474-1","volume":"18","author":"D Kalogeropoulos","year":"2018","unstructured":"Kalogeropoulos D, Papoudou-Bai A, Kanavaros P, Kalogeropoulos C. Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue. Clin Exp Med. 2018;18(2):151\u201363.","journal-title":"Clin Exp Med"},{"issue":"4","key":"2108_CR22","first-page":"136","volume":"6","author":"E Akuaku-Dogbe","year":"2016","unstructured":"Akuaku-Dogbe E, Ekem I, Mensah B. Orbital and adnexal lymphomas among adult patients in Ghana. J West Afr Coll Surg. 2016;6(4):136\u201354.","journal-title":"J West Afr Coll Surg"},{"issue":"4","key":"2108_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00004397-199703740-00005","volume":"37","author":"GC Cockerham","year":"1997","unstructured":"Cockerham GC, Jakobiec FA. Lymphoproliferative disorders of the ocular adnexa. Int Ophthalmol Clin. 1997;37(4):39\u201359.","journal-title":"Int Ophthalmol Clin"},{"key":"2108_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.critrevonc.2016.01.009","volume":"100","author":"O Annibali","year":"2016","unstructured":"Annibali O, Sabatino F, Mantelli F, Olimpieri OM, Bonini S, Avvisati G. Review article: mucosa-associated lymphoid tissue (MALT)-type lymphoma of ocular adnexa. Biology and treatment. Crit Rev Oncol Hematol. 2016;100:37\u201345.","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02108-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-02108-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02108-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T20:28:26Z","timestamp":1632428906000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-02108-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2108"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-02108-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"15 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the procedures conformed to the tenets of the World Medical Association Declaration of Helsinki. A written informed consent was obtained from a parent and\/or legal guardian for subjects below 18\u2009years. Otherwise, a written informed consent was directly obtained from all participants except for subjects below 18\u2009years. An approval for the study was obtained from the Institutional Review Board of the Graduate School of Medicine, Chiba University, Japan (IRB#3848).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}